| Kishoria N, 2020 |
IVERMECTIN AS ADJUVANT TO HYDROXYCHOLOROQUINE IN PATIENTS RESISTANT TO STANDARD TREATMENT FOR SARS-CoV-2: RESULTS OF AN OPEN-LABEL RANDOMIZED CLINICAL STUDY |
| Amra B, ResearchSquare, 2021 |
Thalidomide for the treatment of severe Covid-19: A randomized clinical trial |
| Bundgaard H, Ann Intern Med. 2020 |
Effectiveness of Adding a Mask Recommendation to Other Public Health Measures to Prevent SARS-CoV-2 Infection in Danish Mask Wearers |
| Chahla RE, medRxiv, 2021 |
A RANDOMIZED TRIAL - INTENSIVE TREATMENT BASED IN IVERMECTIN AND IOTA-CARRAGEENAN AS PRE-EXPOSURE PROPHYLAXIS FOR COVID- 19 IN HEALTHCARE AGENTS |
| Ghaderkhani S, ResearchSquare, 2021 |
Efficacy and Safety of Arbidol in Treatment of Patients with COVID-19 Infection: A Randomized Clinical Trial |
| Ghahremani M, ResearchSquare, 2021 |
Exogenous Surfactant Versus Placebo in the Treatment of Moderate and Severe ARDS in COVID-19: The Pilot Study of a Clinical Trial |
| Ghati N, SSRN, 2021 |
A Randomis ed Control Trial of Statin and Asp irin as Adjuvant Therapy in Patients with SARS-CoV-2 Infec tion (RESIST Trial) |
| Grieco DL, JAMA, 2021 |
Effect of Helmet Noninvasive Ventilation vs High-Flow Nasal Oxygen on Days Free of Respiratory Support in Patients With COVID-19 and Moderate to Severe Hypoxemic Respiratory Failure: The HENIVOT Randomized Clinical Trial. |
| Hadanny A, SSRN, 2021 |
Hyperbaric Oxygen Therapy for COVID-19 Patients: A Prospective, Randomized Controlled Trial |
| JayakumarD, medRxiv, 2021 |
Awake prone position in adult nonintubated patients with acute hypoxaemic respiratory failure secondary to COVID-19:A multi-centre feasibility randomized controlled trial |
| Johnston C, SSRN, 2021 |
Hydroxychloroquine with or Without Azithromycin for Treatment of Early SARS-CoV-2 Infection Among High-Risk Outpatient Adults: A Randomized Clinical Trial |
| Kamran SM, Cureus, 2021 |
Clearing the Fog: Is Hydroxychloroquine Effective in Reducing Coronavirus Disease-2019 Progression? A Randomized Controlled Trial |
| Kharat A, SSRN, 2020 |
Self-Proning in COVID-19 Patients on Low-Flow Oxygen Therapy: A Cluster Randomised Controlled Trial |
| Lin YR, J Aerosol Med Pulm Drug Deliv, 2021 |
Mycobacterium vaccae Nebulization in the Treatment of COVID-19: A Randomized, Double-Blind, Placebo-Controlled Trial. |
| Mahajan L, Indian J Anaesth, 2021 |
Clinical outcomes of using remdesivir in patients with moderate to severe COVID-19: A prospective randomised study. |
| Mikhaylov E, medRxiv, 2021 |
Bromhexine Hydrochloride Prophylaxis of COVID-19 for Medical Personnel: A Randomized Open-Label Study |
| Papachristofilou A, Int J Radiat Oncol Biol Phys, 2021 |
Low dose radiation therapy for severe COVID-19 pneumonia: a randomized double-blind study. |
| Patel O, J. Med. Virol, 2021 |
A pilot double-blind safety and feasibility randomised controlled trial of high-dose intravenous zinc in hospitalised COVID-19 patients. |
| Perlin DS, medRxiv, 2021 |
CERC-002, a human anti-LIGHT mAb reduces respiratory failure and death in hospitalized COVID-19 ARDS patients |
| Pouladzadeh M, Intern Emerg Med, 2021 |
A randomized clinical trial evaluating the immunomodulatory effect of convalescent plasma on COVID-19-related cytokine storm. |
| Puskarich M, SSRN, 2021 |
Effect of Losartan on Symptomatic Outpatients with COVID-19: A Randomized Clinical Trial |
| Rasheed A, Le Infezioni in Medicina, 2020 |
The therapeutic potential of convalescent plasma therapy on treating critically-ill COVID-19 patients residing in respiratory care units in hospitals in Baghdad, Iraq |
| Sheng C, Clin Cardiol. 2020 |
Canakinumab to Reduce Deterioration of Cardiac and Respiratory Function in Sars-cov2 Associated Myocardial Injury With Heightened Inflammation (canakinumab in Covid-19 Cardiac Injury): Results From the Randomized Three C Study |
| Vetrici MA, J Inflamm Res, 2021 |
Evaluation of Adjunctive Photobiomodulation (PBMT) for COVID-19 Pneumonia via Clinical Status and Pulmonary Severity Indices in a Preliminary Trial. |
| Youssef J, SSRN, 2021 |
Effectiveness of ZYESAMIâ„¢ (Aviptadil) in Accelerating Recovery and Shortening Hospitalization in Critically-Ill Patients with COVID-19 Respiratory Failure: Interim Report from a Phase 2B/3 Multicenter Trial |
| Yu LM, medRxiv, 2021 |
Inhaled budesonide for COVID-19 in people at higher risk of adverse outcomes in the community: interim analyses from the PRINCIPLE trial |
In addition to 11 RCT evaluating Non-pharmacological interventions and long COVID treatments included and pending extraction: